Pixacare announces the closing of its second funding round, raising €3 million led by Elaia, alongside the French Tech Seed fund managed by Bpifrance on behalf of the French State as part of the France 2030 investment plan. Existing investors including 50partners and several business angels have renewed their support. A debt component completes the financing. The round will accelerate the development of Pixacare's medical application, which automates wound healing monitoring for healthcare professionals.
Improving the care pathway for 2.5 million patients
Pixacare is building a secure, collaborative application for clinical teams to monitor wound healing remotely. The company's ambition is to improve the care pathway for the 2.5 million people living with chronic wounds in France. By strengthening coordination between hospital and community care, the platform aims to reduce hospitalisation lengths and the frequency of in-person consultations — lowering healthcare costs and improving patient quality of life.
Early study results are promising: remote wound monitoring with Pixacare could reduce healing time by 33%, cut follow-up consultations by 55%, and lower the cost per patient by €1,500 over six months.
Becoming the European leader in AI-assisted wound monitoring
This funding round supports three strategic priorities:
- Commercial expansion across France
- Regulatory validation of AI-powered wound analysis algorithms
- Clinical studies to measure the medico-economic impact of remote monitoring, with a view to formal reimbursement by national health insurance
"We are proud to have attracted prestigious investors who believe in our vision, despite a challenging funding environment. This second round marks the arrival of recognised institutional investors among our shareholders — a crucial milestone as we pursue our ambitions for the next three years. The international expertise and network of Elaia and Bpifrance are invaluable assets for a medtech company like ours, with ambitions well beyond France." - Matis Ringdal, CEO and co-founder of Pixacare
"We are delighted to announce our investment in Pixacare. The company is positioning itself as a key player in digital health, offering innovative technology for wound analysis and monitoring. Pixacare addresses the challenges of medical data security, improved patient care and stronger hospital-community collaboration. We are confident in their ability to scale across Europe." - Céline Passedouet, Investment Director at Elaia
"Having supported Pixacare with convertible bonds through the French Tech Seed programme, Bpifrance is proud to back their commercial acceleration and continued technological innovation. Pixacare has all the ingredients to become the reference player in wound monitoring." - Eva Clerc, Senior Investment Director at Bpifrance
About Pixacare
Founded in 2019 by Professor Frédéric Bodin, plastic surgeon at Strasbourg University Hospital, with the support of SATT Conectus and co-founders Matis Ringdal and Vincent Marceddu, Pixacare has rapidly established itself within the French healthcare landscape. The company has earned the trust of leading university hospitals and Unicancer centres, and now counts more than thirty healthcare institutions among its clients — securing photographs and centralising wound monitoring data for 70,000 patients.
Since its first funding round of €2 million in 2021, Pixacare has obtained CE marking as a medical device and ISO 13485 certification for its quality management system. The team of around twenty people is based in Strasbourg, within Nextmed — a European centre of reference for health innovation.
About Elaia
Elaia is a leading European venture capital firm with a strong technology focus. The firm invests in high-potential digital and deep tech startups from the earliest stages, supporting them through to global leadership. Over twenty years, Elaia has been the first professional investor in more than 100 startups, including Criteo (Nasdaq), Mirakl (valued at $3.5 billion in Series E) and Shift Technology (valued at over $1 billion in Series D).
About Bpifrance and the French Tech Seed fund
Bpifrance finances companies at every stage of development through loans, guarantees and equity. The French Tech Seed fund, endowed with €500 million and operated by Bpifrance on behalf of the French State under the France 2030 plan, supports fundraising for innovative startups under three years old with high technological intensity.
About France 2030
France 2030 is a €54 billion public investment plan designed to transform key sectors of the French economy through technological innovation and position France as a leader in the industries of tomorrow. The plan is overseen by the Secrétariat général pour l'investissement on behalf of the Prime Minister, and implemented by ADEME, ANR, Bpifrance and the Caisse des Dépôts.
Press contacts
Pixacare: Aurélie Garcin, CMO — +33 (0)7 55 50 39 46 — aurelie.garcin@pixacare.comElaia: Louisa Mesnard, CMO — lmesnard@elaia.comBpifrance: Juliette Fontanillas, Media Relations — +33 (0)6 72 76 08 09 — juliette.fontanillas@bpifrance.fr
Références
[1] P. Y. Courcoux. Master's thesis, École des Hautes Études en Santé Publique. A chronic wound care pathway for patient support across health territories: what is the public health case? 2011.[2] Study pending publication. Clinical and medico-economic benefits of remote monitoring of chronic wounds. Guillaume Maxant et al. Vascular Surgery Department, CH de Haguenau.
